XPOVIO
Active substance: selinexor
TABLET, FILM COATED · SELINEXOR 50 mg/1
United StatesActive
Marketing holder: Karyopharm Therapeutics Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- SELINEXOR · 50 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-c927-7339-857c-f109a8063b4f,01a12090-dd3a-776d-9818-4c691ac705c3,01a12095-154b-736f-aa9e-1d7b6a0e09b4,01a12097-3e25-746c-be89-01066535e383,01a12099-c1a2-7f11-9696-0e68a058d0ca;count=6 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 72237-103
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 72237-103 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 72237-103 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 72237-103 · Verified 2026-10-09 · open in source